Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Safety and pharmacokinetics of subcutaneously administered rilonacept in patients with well-controlled end-stage renal disease (ESRD).
J Clin Pharmacol. 2010 Jul;50(7):835-41. doi: 10.1177/0091270009351882. Epub 2009 Dec 24.
J Clin Pharmacol. 2010.
PMID: 20035038
Clinical Trial.
Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.
Hoffman HM, Throne ML, Amar NJ, Sebai M, Kivitz AJ, Kavanaugh A, Weinstein SP, Belomestnov P, Yancopoulos GD, Stahl N, Mellis SJ.
Hoffman HM, et al. Among authors: belomestnov p.
Arthritis Rheum. 2008 Aug;58(8):2443-52. doi: 10.1002/art.23687.
Arthritis Rheum. 2008.
PMID: 18668535
Free article.
Clinical Trial.
Item in Clipboard
Cryopyrin-associated periodic syndromes: development of a patient-reported outcomes instrument to assess the pattern and severity of clinical disease activity.
Hoffman HM, Wolfe F, Belomestnov P, Mellis SJ.
Hoffman HM, et al. Among authors: belomestnov p.
Curr Med Res Opin. 2008 Sep;24(9):2531-43. doi: 10.1185/03007990802297495. Epub 2008 Jul 29.
Curr Med Res Opin. 2008.
PMID: 18667113
Item in Clipboard
Cite
Cite